Large tumor suppressor 2 is a prognostic biomarker and correlated with immune infiltrates in colorectal cancer
Colorectal cancer (CRC) is a common malignancy that has both low 5-year survival and high prevalence. Immunotherapy has achieved impressive progress for treatment of CRC, but still faces huge challenges. Although large tumor suppressor 2 (LATS2) is well accepted to be related to cancer progression,...
Guardado en:
Autores principales: | Chengwen Zhao, Jianping Chen, Yonghui Liu, Shaoqing Ju, Guihua Wang, Xudong Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Taylor & Francis Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e6deff1a934742f98d5f23f95d2767cf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Overexpression of small nucleolar RNA SNORD1C is associated with unfavorable outcome in colorectal cancer
por: Yonghui Liu, et al.
Publicado: (2021) -
A novel identified pyroptosis-related prognostic signature of colorectal cancer
por: Chen Zheng, et al.
Publicado: (2021) -
Integrative analysis of prognostic value and immune infiltration of spindle and kinetochore-associated family members in breast cancer
por: Jianfeng Ding, et al.
Publicado: (2021) -
Aryl hydrocarbon receptor is a prognostic biomarker and is correlated with immune responses in cervical cancer
por: Jiasui Wang, et al.
Publicado: (2021) -
Identification of circRNA_001846 as putative non–small cell lung cancer biomarker
por: Fan Yang, et al.
Publicado: (2021)